Christopher Morin is categorized under Physical Medicine, Physician/Surgeon in Bethlehem, PA and active since 2010.
Christopher Morin was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Physical Medicine, Physician/Surgeon business, which does work in the B2C market, and is classified as a Physical Medicine, Physician/Surgeon, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Christopher Morin at the company’s single location by writing to 2830 Easton Avenue, Bethlehem, Pennsylvania PA 18017 or by phoning (610) 954-3555. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Christopher Morin |
| Contact Person: | Christopher Morin |
| Address: | 2830 Easton Avenue, Bethlehem, Pennsylvania 18017 |
| Phone Number: | (610) 954-3555 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Physical Medicine, Physician/Surgeon |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Christopher Morin was started in 2010 to provide professional Physical Medicine, Physician/Surgeon under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Christopher Morin for inquiries that concern Christopher Morin by calling the company number (610) 954-3555, as your correspondence is most welcome. Additionally, the physical location of the single location of Christopher Morin can be found at the coordinates 40.647448,-75.341493 as well as the street address 2830 Easton Avenue in Bethlehem, Pennsylvania 18017.
For its online presence, you may visit Christopher Morin’s website at and engage with its social media outlets through on Twitter and on Facebook.